The impact of drug-induced QT interval prolongation on drug discovery and development
Year: 2003
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd1108
Authors: Bernard Fermini, Anthony A. Fossa
Institution: Pfizer (United States)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2052017927
